Compagnie Lombard Odier SCmA’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-761
Closed -$79.1K – 543
2020
Q1
$68K Buy
+761
New +$98.5K ﹤0.01% 333
2017
Q4
– Sell
-936
Closed -$74K – 662
2017
Q3
$74K Hold
936
– – ﹤0.01% 487
2017
Q2
$82K Hold
936
– – ﹤0.01% 458
2017
Q1
$83K Buy
+936
New +$78K ﹤0.01% 470
2014
Q4
– Sell
-2,111
Closed -$149K – 804
2014
Q3
$149K Buy
2,111
+1,531
+264% +$101K 0.01% 569
2014
Q2
$33K Hold
580
– – ﹤0.01% 779
2014
Q1
$30K Sell
580
-3,919
-87% -$195K ﹤0.01% 765
2013
Q4
$215K Buy
+4,499
New +$208K 0.01% 510

Other funds holding HCA

Compagnie Lombard Odier SCmA's HCA Position: Q2 2020 in Review

Compagnie Lombard Odier SCmA sold out of HCA Healthcare (HCA) in Q2 2020, closing a stake of 761 shares — an estimated $79.1K sold.

Compagnie Lombard Odier SCmA first reported a position in HCA in Q4 2013 and held it in 8 quarters. The position peaked at $215K in Q4 2013. 686 funds tracked by Wall St. Rank hold HCA as of Q2 2020.

  • Compagnie Lombard Odier SCmA reported no remaining HCA Healthcare position as of Q2 2020 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 761 HCA Healthcare shares in Q2 2020, an estimated $79.1K.
  • Compagnie Lombard Odier SCmA first reported a position in HCA Healthcare in Q4 2013 and held it in 8 quarters.
  • Compagnie Lombard Odier SCmA's HCA Healthcare position peaked at $215K in Q4 2013.
  • 686 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2020.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2020, filed 14 Aug 2020.